Westat researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.


Bartels S.J., Aschbrenner K.A., Pratt S.I., Zubkoff L., Jue K., Williams G., Godfrey M.M., Cohen M.J., Banerjee S., Xie H., Wolfe R., Naslund J.A., and Bond G.R. (2022).

Virtual learning collaborative compared to technical assistance as a strategy for implementing health promotion in routine mental health settings: A hybrid type 3 cluster randomized trial.

Gaglani M., Kim S.S., Naleway A.L., Levine M.Z., Edwards L., Murthy K., Dunnigan K., Zunie T., Groom H., Ball S., Jeddy Z., Hunt D., Wesley M.G., Sambhara S., Gangappa S., Grant L., Cao W., Liaini Gross F., Mishina M., Fry A.M., Thompson M.G., Dawood F.S., and Flannery B. (2022).

Effect of repeat vaccination on immunogenicity of quadrivalent cell-culture and recombinant influenza vaccines among healthcare personnel aged 18–64 Years: A randomized, open-label trial.

Britton A., Embi P.J., Levy M.E., Gaglani M., DeSilva M.B., Dixon B.E., Dascomb K., Patel P., Schrader K.E., Klein N.P., Ong T.C., Natarajan K., Hartmann E., Kharbanda A.B., Irving S.A., Dickerson M., Dunne M.M., Raiyani C., Grannis S.J., Stenehjem E., Zerbo O., Rao S., Han J., Sloan-Aagard C., Griggs E.P., Weber Z.A., Murthy K., Fadel W.F., Grisel N., McEvoy C., Lewis N., Barron M.A., Nanez J., Reese S.E., Mamawala M., Valvi N.R., Arndorfer J., Goddard K., Yang D.-H., Fireman B., Ball S.W., Link-Gelles R., Naleway A.L., and Tenforde M.W. (2022).

Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 omicron predominance — VISION Network, 10 states, December 2021–August 2022.

Williams R., Cao P., Li T., Luta G., Smith L., Mandelblatt J., Jeon J., Zhao A., Levy D., Davis K., Stanton C., Niaura R., Abrams D., Lobo T., Anderson E., Meza R., Jayasekera J., and Taylor K.L. (2022).

A randomized trial of telephone-based smoking cessation treatment in the lung cancer screening setting.

Mueller A.S., Cicchino J.B., Benedick A., De Leonardis D., and Huey R. (2022).

Bears in our midst: Familiarity with Level 2 driving automation and attending to surprise on-road events.

Yan T. and Tourangeau R. (2022).

Detecting underreporters of abortions and miscarriages in the National Study of Family Growth, 2011–2015.

Tatalovich Z., Stinchcomb D.G., Ng D., Yu M., Lewis D.R., Zhu L., and Feuer E.J.R. (2022).

Developing geographic areas for cancer reporting using automated zone design.

Flerlage J.E., Myers J.R., Maciaszek J.L., Oak N., Rashkin S.R., Hui Y., Wang Y.-D., Chen W., Wu G., Chang T.-C., Hamilton K.V., Goldin L.R., Rotunno M., Caporaso N.E., Vogt A., Flamish D., Wyatt K., Liu J., Tucker M.A., Mullighan C.G., Nichols K.E., Metzger M.L., McMaster M.L., Yang J.J., and Rampersaud E. (2022).

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

Etemadi A., Buller I.D., Hashemian M., Roshandel G., Poustchi H., Espinosa M.M., Blount B.C., Pfeiffer C.M., Keshavarzi B., Flory A.R., Nasseri-Moghaddam S., Dawsey S.M., Freedman N.D., Abnet C.C., Malekzadeh R., and Ward M.H. (2022).

Urinary nitrate and sodium in a high-risk area for upper gastrointestinal cancers: Golestan Cohort Study.

Ferdinands J.M., Rao S., Dixon B.E., Mitchell P.K., DeSilva M.B., Irving S.A., Lewis N., Natarajan K., Stenehjem E., Grannis S.J., Han J., McEvoy C., Ong T.C., Naleway A.L., Reese S.E., Embi P.J., Dascomb K., Klein N.P., Griggs E.P., Konatham D., Kharbanda A.B., Yang D.-H., Fadel W.F., Grisel N., Goddard K., Patel P., Liao I.-C., Birch R., Valvi N.R., Reynolds S., Arndorfer J., Zerbo O., Dickerson M., Murthy K., Williams J., Bozio C.H., Blanton L., Verani J.R., Schrag S.J., Dalton A.F., Wondimu M.H., Link-Gelles R., Azziz-Baumgartner E., Barron M.A., Gaglani M., Thompson M.G., and Fireman B. (2022).

Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 States.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.